Article
A multivariable model for improved prediction of kidney failure requiring kidney replacement therapy based on routine laboratory parameters
Search Medline for
Authors
Published: | February 26, 2021 |
---|
Outline
Text
Identification of chronic kidney disease (CKD) patients, who are at risk of progressing to kidney failure requiring kidney replacement therapy (KRT), frequently also designated as end-stage kidney disease (ESKD), is important for clinical decision-making and clinical trial design and enrollment.
We report a new 6-variable risk model based on routine laboratory parameters that predicts progression to ESKD requiring KRT initiation in patients with CKD stages G3 together with A1-3 or G1-2 together with A3. To develop this model, we analyzed data from 4,915 patients from the longterm prospective observational German Chronic Kidney Disease (GCKD) cohort study. During an observation period of 3.71 ± 0.88 years, 200 of the 4,915 patients (4.07%) progressed to initiation of KRT, defined as initiation of long-term dialysis or kidney transplantation. A LASSO Cox proportional hazards model was trained and tested in a resampling approach and achieved a median concordance (C) index of 0.899 (95% CI, 0.871-0.920). Comprising the variables serum creatinine, albumin, cystatin C, and urea, as well as hemoglobin and the urine albumin-to-creatinine ratio, the new risk model outperformed the 5-year, 4-variable Tangri risk equation, currently the golden standard to predict ESKD events in CKD patients, which achieved a median C index of 0.866 (95% CI, 0.830-0.897) in the resampling approach. Likewise, the novel 6-variable risk equation always yielded positive net reclassification improvements (NRI) in comparison to the Tangri risk equation evaluated one, two, three, and four years after the baseline visit.
This 6-variable risk score further outperformed the Tangri risk score in three independent, international validation cohorts comprising, in total, 3,064 CKD patients, with improvements in C statistics ranging from 0.010 to 0.018.
In conclusion, the proposed risk model based on easily accessible routine laboratory parameters led to a marked improvement in the distinction of CKD patients likely to progress to ESKD requiring KRT.
The authors declare that they have no competing interests.
The authors declare that a positive ethics committee vote has been obtained.